chr3-189737892-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003722.5(TP63):c.191+24T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0496 in 1,613,296 control chromosomes in the GnomAD database, including 2,544 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.035 ( 197 hom., cov: 32)
Exomes 𝑓: 0.051 ( 2347 hom. )
Consequence
TP63
NM_003722.5 intron
NM_003722.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.761
Publications
3 publications found
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
- ADULT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ankyloblepharon-ectodermal defects-cleft lip/palate syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- limb-mammary syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Rapp-Hodgkin syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- premature ovarian failure 21Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- split hand-foot malformation 4Inheritance: AD Classification: MODERATE Submitted by: Illumina
- EEC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- split hand-foot malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-189737892-T-C is Benign according to our data. Variant chr3-189737892-T-C is described in ClinVar as Benign. ClinVar VariationId is 259131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.058 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TP63 | NM_003722.5 | c.191+24T>C | intron_variant | Intron 2 of 13 | ENST00000264731.8 | NP_003713.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TP63 | ENST00000264731.8 | c.191+24T>C | intron_variant | Intron 2 of 13 | 1 | NM_003722.5 | ENSP00000264731.3 |
Frequencies
GnomAD3 genomes AF: 0.0354 AC: 5391AN: 152100Hom.: 197 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5391
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0379 AC: 9475AN: 250330 AF XY: 0.0377 show subpopulations
GnomAD2 exomes
AF:
AC:
9475
AN:
250330
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0510 AC: 74549AN: 1461078Hom.: 2347 Cov.: 31 AF XY: 0.0501 AC XY: 36421AN XY: 726834 show subpopulations
GnomAD4 exome
AF:
AC:
74549
AN:
1461078
Hom.:
Cov.:
31
AF XY:
AC XY:
36421
AN XY:
726834
show subpopulations
African (AFR)
AF:
AC:
259
AN:
33460
American (AMR)
AF:
AC:
745
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
118
AN:
26118
East Asian (EAS)
AF:
AC:
2
AN:
39614
South Asian (SAS)
AF:
AC:
1314
AN:
86236
European-Finnish (FIN)
AF:
AC:
3045
AN:
53356
Middle Eastern (MID)
AF:
AC:
150
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
66493
AN:
1111476
Other (OTH)
AF:
AC:
2423
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3281
6561
9842
13122
16403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2376
4752
7128
9504
11880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0354 AC: 5392AN: 152218Hom.: 197 Cov.: 32 AF XY: 0.0339 AC XY: 2526AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
5392
AN:
152218
Hom.:
Cov.:
32
AF XY:
AC XY:
2526
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
327
AN:
41544
American (AMR)
AF:
AC:
239
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
17
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
83
AN:
4830
European-Finnish (FIN)
AF:
AC:
591
AN:
10604
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4045
AN:
67984
Other (OTH)
AF:
AC:
60
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
255
510
766
1021
1276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
30
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.